Ethics and Financial Disclosure Transparency within the clinical research process is a core goal of trial registries such as ClinicalTrials.gov. To prepare for this Discussion, reflect back on the themes that were presented in CLRA 6130: Ethical, Legal, and Regulatory Considerations in Clinical Investigations and how they are echoed in this week’s Learning Resources. Consider how ethical behavior and scientific integrity are intertwined. By Day 4, post a comprehensive response to the following: Why is it appropriate for federal regulatory authorities to require the principal investigator to disclose any financial interest in a sponsor company that he or she is conducting clinical trials for? How might financial disclosure create a problematic ethical situation? Include an example scenario in your post to illustrate your answer. please give references and examples.
Sample Solution
